Municipal State Enterprise on the Right of Economic Management “East Kazakhstan Region Specialized Medical Center” of Health Care Administration of East Kazakhstan Region
, Ust-Kamenogorsk
, Kazakhstan
Aim Stroke treatment is a time-critical condition. Understanding the impact of timing and types of treatment on patient outcomes can help develop and optimize stroke management strategies. The study aimed to analyse the effect of different time intervals and mechanical thrombectomy methods on outcomes of stroke patients in Kazakhstan. Methods The patient data, including demographic information, clinical characteristics, and specific time intervals from stroke onset to hospital admission, stroke onset to surgery initiation, and hospital admission to surgery initiation were collected. A total of 100 patients were analysed. Patients’ neurological status was evaluated using the National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (mRS), and Glasgow Coma Scale (GCS) before and after the surgical treatment. Results Most patients had concomitant arterial hypertension, and almost 25 % had diabetes mellitus. The average time from stroke onset to hospital admission was 123.2±7.6 minutes, and from hospital admission to surgery initiation, it was 134.7±13.1 minutes. A shorter duration from the onset of stroke to hospitalization and surgery was associated with better clinical outcomes. Our results demonstrated a statistically significant decrease in NIHSS, mRS after surgical treatment compared to baseline. The association between the extended time from stroke onset to hospitalization and reduced survival rates was observed. Conclusion Our findings indicate the essential role of timely intervention in managing stroke patients, as well as the need for a comprehensive and patient-centred approach to stroke care.
Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, et al. Temporal trend and attributable risk factors of stroke burden in China. Lancet Public Health. 1990;897-e906.
2.
Zhakhina G, Zhalmagambetov B, Gusmanov A, Sakko Y, Yerdessov S, Matmusaeva E, et al. Incidence and mortality rates of strokes in Kazakhstan in 2014-2019. Sci Rep. 2022;16041.
3.
Schott A, Termoz A, Viprey M, Tazarourte K, Vecchia C, Bravant E, et al. Short and long-term impact of four sets of actions on acute ischemic stroke management in Rhône County, a population based before-and-after prospective study. BMC Health Serv Res. 2021;12.
4.
Yafasova A, Fosbøl E, Johnsen S, Kruuse C, Petersen J, Alhakak A, et al. Time to thrombolysis and long-term outcomes in patients with acute ischemic stroke: a nationwide study. Stroke. 2021;1724–32.
5.
Shokri H, Nahas E, Aref N, Dawood H, Abushady N, E, et al. Wahid El Din MM, Roushdy TM. Factors related to time of stroke onset versus time of hospital arrival: a SITS registry-based study in an Egyptian stroke center. PLoS One. 2020;238305.
6.
Gonzalez-Aquines A, Cordero-Perez A, Ramirez-Martinez L, Sanchez-Teran H, Escobedo-Zuñiga N, Herrera T, et al. Onset-to-alarm time in patients with acute stroke: Results from a Mexican population. International journal of stroke: official journal of the Int J Stroke. 2018;
7.
Nepal G, Yadav J, Basnet B, Shrestha T, Kharel G, Ojha R. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal. BMC Neurol. 2019;155.
8.
Ni W, Kunz W, Goyal M, Chen L, Jiang Y. Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China. Health Econ Rev. 2022;4.
9.
Hasan T, Hasan H, Kelley R. Overview of acute ischemic stroke evaluation and management. Biomedicines. 2021;1486.
10.
Kunz W, Hunink M, Almekhlafi M, Menon B, Saver J, Dippel D, et al. Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke. Neurology. 2020;2465-2e75.
11.
Budinčević H, Meštrović A, Demarin V. Stroke Scales as Assessment Tools in Emergency Settings: A Narrative Review. 2022;1541.
12.
Rebchuk A, Neill O, Szefer Z, Hill E, Field M, T. Health utility weighting of the modified rankin scale: a systematic review and meta-analysis. JAMA Netw Open. 2020;
13.
Bodien Y, Barra A, Temkin N, Barber J, Foreman B, Vassar M, et al. Diagnosing level of consciousness: the limits of the Glasgow Coma Scale total score. J Neurotrauma. 2021;3295–305.
14.
International Classification of Diseases,Tenth Revision. 13AD;10.
15.
Barber P, Demchuk A, Zhang J, Buchan A. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;1670–4.
16.
Marks M, Lansberg M, Mlynash M, Kemp S, Mctaggart R, Zaharchuk G, et al. Correlation of AOL recanalization, TIMI reperfusion and TICI reperfusion with infarct growth and clinical outcome. J Neurointerv Surg. 2014;724–8.
17.
Behme D, Tsogkas I, Colla R, Gera R, Schregel K, Hesse A, et al. Validation of the extended thrombolysis in cerebral infarction score in a real world cohort. PLoS One. 2019;210334.
18.
Clinical Protocol of Stroke in Kazakhstan. 2016;
19.
Powers W, Rabinstein A, Ackerson T, Adeoye O, Bambakidis N, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the. Stroke. 2019;344-e418.
20.
Ari B. Retrospective analysis of the data of patients who were admitted to the secondary care hospital with the diagnosis of acute ischemic stroke and received intravenous thrombolytic therapy. North Clin Istanb. 2023;139–45.
21.
Li X, Wu L, Xie H, Bao Y, He D, Luo X. Endovascular treatment for ischemic stroke beyond the time window: a meta-analysis. Acta Neurol Scand. 2020;3–13.
22.
De Havenon A, Alexander M, Nogueira R, Haussen D, Castonguay A, Linfante I, et al. Duration of symptomatic stroke and successful reperfusion with endovascular thrombectomy for anterior circulation large vessel occlusive stroke. J Neurointerv Surg. 2021;1128–31.
23.
Fransen P, Beumer D, Berkhemer O, Van Den Berg L, Lingsma H, Van Der Lugt A, et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials. 2014;343.
24.
Nogueira R, Jadhav A, Haussen D, Bonafe A, Budzik R, Bhuva P, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2017;11–21.
25.
Albers G, Lansberg M, Kemp S, Tsai J, Lavori P, Christensen S, et al. Marks MP. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017;896–905.
26.
Demchuk A, Goyal M, Menon B, Eesa M, Ryckborst K, Kamal N, et al. Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke. 2015;429–38.
27.
Veunac L, Saliou G, Knebel J, Bartolini B, Puccinelli F, Michel P, et al. Revascularization of carotid artery occlusion using stenting versus non stenting in endovascular management of tandem occlusion stroke. J Clin Neurosci. 2022;15–20.
28.
Sheng K, Tong M. Aspiration thrombectomy for posterior circulation stroke: a systematic review and meta-analysis. Asian J Neurosurg. 2020;251–61.
29.
Meyer L, Stracke P, Wallocha M, Broocks G, Sporns P, Piechowiak E, et al. Aspiration versus stent retriever thrombectomy for distal. Stroke. 2022;2449–57.
30.
Texakalidis P, Giannopoulos S, Karasavvidis T. Rangel-Castilla L, Rivet DJ, Reavey-Cantwell J. Mechanical Thrombectomy in Acute Ischemic Stroke: A meta-analysis of stent retrievers vs direct aspiration vs a combined approach. Neurosurgery. 2020;464–77.
31.
Sorita A, Ahmed A, Starr S, Thompson K, Reed D, Dabrh A, et al. Off-hour presentation and outcomes in patients with acute ischemic stroke: a systematic review and meta-analysis. Eur J Intern Med. 2014;394–400.
32.
Zakaria M, Aref H, Elnasser A, Fahmy A, Tork N, Fouad M, et al. Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke. Int J Stroke. 2018;525–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
